In Canada, South Asian communities are at a higher risk of developing Type 2 diabetes compared to the general population. As a result, South Asian populations experience significant morbidity and mortality.
As a Canadian with Type 1 diabetes I’m dismayed by the way pharmaceutical companies have driven up insulin prices, created a global oligarchy and increased the burden on those who need this life-giving medicine.
The pandemic has been stressful for everyone, but for people with diabetes who experience social marginalization and inequity, that stress can be especially dangerous.